Canada Eyelashes Enhancing Agents Market, By Content,
Canada Eyelashes Enhancing Agents Market, By Content,
By Content, the market is segmented into Bimatoprost, Lash-building serum, Skincare Ingredients, Herbal Remedy, Isopropyl Cloprostenate, Enhancer Serum, and Others (2017-2027)
| Label | Bimatoprost | Lash-building serum | Skincare Ingredients | Herbal Remedy | Isopropyl Cloprostenate | Enhancer Serum | Others | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | 6.42 USD Mn | 1.26 USD Mn | 1.67 USD Mn | 3.32 USD Mn | 1.23 USD Mn | 5.74 USD Mn | 3.42 USD Mn | 23.06 USD Mn |
| 2018 | 6.82 USD Mn | 1.35 USD Mn | 1.79 USD Mn | 3.54 USD Mn | 1.29 USD Mn | 6.06 USD Mn | 3.59 USD Mn | 24.43 USD Mn |
| 2019 | 7.23 USD Mn | 1.43 USD Mn | 1.9 USD Mn | 3.76 USD Mn | 1.36 USD Mn | 6.39 USD Mn | 3.77 USD Mn | 25.84 USD Mn |
| 2020 | 7.65 USD Mn | 1.52 USD Mn | 2.03 USD Mn | 4 USD Mn | 1.42 USD Mn | 6.73 USD Mn | 3.94 USD Mn | 27.28 USD Mn |
| 2021 | 7.95 USD Mn | 1.59 USD Mn | 2.12 USD Mn | 4.17 USD Mn | 1.46 USD Mn | 6.96 USD Mn | 4.05 USD Mn | 28.3 USD Mn |
| 2022 | 8.28 USD Mn | 1.66 USD Mn | 2.22 USD Mn | 4.36 USD Mn | 1.5 USD Mn | 7.21 USD Mn | 4.17 USD Mn | 29.42 USD Mn |
| 2023 | 8.66 USD Mn | 1.74 USD Mn | 2.33 USD Mn | 4.58 USD Mn | 1.56 USD Mn | 7.5 USD Mn | 4.31 USD Mn | 30.68 USD Mn |
| 2024 | 9.09 USD Mn | 1.84 USD Mn | 2.46 USD Mn | 4.83 USD Mn | 1.62 USD Mn | 7.83 USD Mn | 4.48 USD Mn | 32.15 USD Mn |
| 2025 | 9.59 USD Mn | 1.95 USD Mn | 2.61 USD Mn | 5.11 USD Mn | 1.68 USD Mn | 8.22 USD Mn | 4.67 USD Mn | 33.82 USD Mn |
| 2026 | 10.12 USD Mn | 2.06 USD Mn | 2.77 USD Mn | 5.42 USD Mn | 1.76 USD Mn | 8.63 USD Mn | 4.87 USD Mn | 35.63 USD Mn |
| 2027 | 10.67 USD Mn | 2.19 USD Mn | 2.93 USD Mn | 5.73 USD Mn | 1.83 USD Mn | 9.05 USD Mn | 5.08 USD Mn | 37.48 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The Canada Eyelashes Enhancing Agents Market, By Content, market is on a steady long-term growth path. Segment value stands at roughly USD 36 Mn in 2026 and is projected to reach USD 37 Mn by 2027 — a gain of about 5% over the forecast period, translating to a CAGR in the mid-single digits.
- Bimatoprost is the biggest of 7 groups as of 2027, at 10. 67M USD (28% of the combined total).
- What the regional split looks like (2026): Bimatoprost leads, holding roughly 28% of segment value — the single largest regional share. Enhancer Serum is the second-largest contributor. Herbal Remedy, Others, Skincare Ingredients, Lash-building serum and Isopropyl Cloprostenate make up the remainder, in descending order.
- By 2027, Bimatoprost alone is expected to reach USD 11 Mn, with Enhancer Serum at USD 9 Mn.
Market Dynamics
Bimatoprost is the biggest of 7 groups as of 2027, at 10.67M USD (28% of the combined total).
Next is Enhancer Serum, at 9.05M USD — 15% behind Bimatoprost.
Bimatoprost climbs from 6.42M USD (2017) to 10.67M USD (2027), a 66% gain.
Enhancer Serum: 5.74M USD to 9.05M USD, 58% higher by 2027.
Herbal Remedy: up 73% over the period, 3.32M USD to 5.73M USD.
Others: 3.42M USD in 2017 to 5.08M USD by 2027, up 49%.
Skincare Ingredients grows to 2.93M USD by 2027, from 1.67M USD in 2017 — 75% up.
Lash-building serum: 1.26M USD in 2017 to 2.19M USD by 2027, up 74%.
By rate of change, not size, Skincare Ingredients is the standout — 75% growth, faster than the rest of the group.
Across the full group, the combined total moves from 23.06M USD in 2017 to 37.48M USD in 2027 — a 63% change.
Making Sense Of 7 Series At Once
There are 7 separate series stacked into this one chart. Look at relative size and relative movement, not just whichever line sits highest.
Size and growth rate are two different questions here — a series can be small in absolute terms and still be growing the fastest of the group. Check both before drawing a conclusion.
Treat these values as a directional estimate of the Canada Eyelashes Enhancing Agents market. They are most useful for comparing segments and regions against each other, and for spotting where demand is expected to build fastest.
Figures before the 2018 base year are historical estimates; the years through 2027 are projections built from industry data, company revenues, and primary interviews. Forecasts are revised as new data comes in, so check the full report for the latest assumptions.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



